The English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) report for 2025-2026 sets out rates of antimicrobial usage, as well as the rates of antimicrobial-resistant (AMR) infections.
The latest report shows an encouraging 10.7% reduction in NHS antibiotic consumption since 2019, which puts England ahead of the 5% reduction target highlighted in the 2024 UK AMR Action Plan. The main driver of this decrease in antibiotic consumption has been due to an 18.8% reduction across general practice.
However, hospital antibiotic consumption remains above pre-pandemic levels, and stewardship efforts in hospital settings remain vital in driving down rates of AMR.
Despite these reductions, the burden of bacteraemia infections continues to rise, with rates increasing by 22.9% since 2019. The report found that the estimated burden of antimicrobial-resistant infections has increased by 16.8% since 2019, although the rate of increase slowed between 2024 and 2025.
The report highlights persistent inequalities in rates of AMR, with older adults, infants, people living in deprived communities and some ethnic minority groups experiencing disproportionately high rates of resistant infection.
Dr Natasha Ratnaraja, Chair of the RCPath Joint Medical Microbiology and Medical Virology Specialty Advisory Committee, said:
"Whilst we are encouraged to see a reduction in the use of antimicrobials across the NHS, particularly in general practice, we remain concerned that the burden of AMR infections continues to increase.
Targeted antimicrobial stewardship can be highly effective in reducing antibiotic usage across different healthcare settings in England. Robust microbiology and pathology services, alongside surveillance data, are essential to ensuring that antimicrobials are used appropriately and that emerging resistance patterns are identified early.
Effective engagement, education and training across the health system are also vital to ensure that antimicrobial use continues to decline, to help arrest further growth in AMR infections wherever possible.
The College will continue to analyse the implications of the ESPAUR report, alongside other infection societies, and to advocate with policymakers for effective antimicrobial stewardship to reduce the AMR burden on the NHS".